Skip to main content

Introducing your host: ClueBot!

By July 12, 2013March 9th, 2022No Comments

CluePoints SMART Engineand I will be bringing to you new and exciting topics in the areas of Risk-Based Monitoring in clinical trials. Some of you may have met me at the recent annual DIA meeting in Boston,

CluePoints - Central Statistical Monitoring

but others may still be unfamiliar with CluePoints and how we can be incorporated into your Risk-Based Monitoring strategy. I may look young, shiny and new but I have you all fooled [aluminum botox injections are my not-so-little secret]. I have actually been perfected over the last decade by the International Drug Development Institute (IDDI) and have been implemented in several dozens of trials to date.  We even have publications in Statistics in Medicine that date back to 1999 and that are cited in the FDA’s Risk-Based Monitoring guidance document, published in 2011. So, what is Central Statistical Monitoring and what exactly does a ‘ClueBot’, like me, do?  Learn more in this short video!

Patrick Hughes

Patrick holds a Marketing degree from the University of Newcastle-upon-Tyne, UK, and a post-graduate Marketing diploma in Business-to-Business Marketing Strategy from Northwestern University - Kellogg School of Management, Chicago, Illinois. Responsible for leading global sales, product, marketing, operational and technical teams throughout his career, Patrick is a Senior Executive with over eighteen years international commercial experience within life sciences, healthcare and telecommunications. In the past, Patrick consulted on corporate and commercial strategy for various life sciences companies and was responsible for successfully positioning ClinPhone as the leading Clinical Technology Organization during his 10-year tenure with the company.